Miscellaneous and General
47 Index.
The expressions listed in the left-hand column below are respectively defined or (as the case may be) are to be interpreted in accordance with the provisions of this Act listed in the right-hand column in relation to those expressions.
Activities governed by this Act | Section 4(5) |
F1Appeals committee | F1Section 20A(2) |
Authority | Section 2(1) |
F2Basic partner treatment services | Section 2(1) |
Carry, in relation to a child | Section 2(3) |
F3. . . | F3. . . |
Directions | Section 2(1) |
F4Distribution, in relation to gametes or embryos intended for human application | Section 2(1) |
Embryo F5(except in section 4A or in the term “human admixed embryo”) | Section 1 |
F6First Directive | Section 1A |
F7Fourth Directive | Section 1A |
Gametes, eggs or sperm F8(except in section 4A) | Section 1 |
F1Human admixed embryo | F1Section 4A(6) |
F9Human application | Section 2(1) |
F7Importing licensee | Section 2B(2 |
Keeping, in relation to embryos or gametes | Section 2(2) |
Licence | Section 2(1) |
F10. . . | F10. . . |
F10. . . | F10. . . |
F11Non-medical fertility services | Section 2(1) |
F1Nuclear DNA (in relation to an embryo) | F1Section 2(1) |
F12Partner-donated sperm | Section 1(5) |
Person responsible | Section 17(1) |
Person to whom a licence applies | Section 17(2) |
F13Person to whom a third party agreement applies | Section 2A(3) |
F14Processing, in relation to gametes or embryos intended for human application | Section 2(1) |
F15Procurement, in relation to gametes or embryos intended for human application | Section 2(1) |
F7Qualifying gametes or embryos | Section 2B(3) |
F16Relevant third party premises, in relation to a licence | Section 2A(2) |
F17Second Directive | Section 1A |
F18Serious adverse event | Section 2(1) |
F19Serious adverse reaction | Section 2(1) |
F20. . . | F20. . . |
Store, and similar expressions, in relation to embryosF21, human admixed embryos or gametes | F22Section 2(1) |
F7Third country | Section 2B(4) |
F7Third country premises | Section 2B(5) |
F7Third country supplier | Section 2B(6) |
F23Third Directive | Section 1A |
F24Third party | Section 2A(2) |
F25Third party agreement | Section 2A(1) |
F26Tissue establishment | Section 2(1) |
F27Traceability | Section 2(1) |
Treatment services | Section 2(1) |